Patents-Review.com
ClassID:

21179 ⎘

A61K2039/541 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies characterised by the route of administration Mucosal route

Sub-classes:
Recent Application in this class:
#1
20260000751
2026-01-01

CORONAVIRUS VACCINES AND METHODS OF USE THEREOF

 #2
20260000746
2026-01-01

ADENOVIRAL VECTOR VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS, AND PREPARATION METHOD THEREFOR AND USE THEREOF

 #3
20250381256
2025-12-18

SUBLINGUAL NANOFIBER VACCINES AND METHODS OF MAKING AND USING SAME

 #4
20250339458
2025-11-06

USES OF MODIFIED RNA ENCODING RETINALDEHYDE DEHYDROGENASE

 #5
20250325661
2025-10-23

VACCINE COMPOSITION

 #6
20250312440
2025-10-09

CHEMICAL SCREEN OF MODULATORS FOR VACCINE ADJUVANTS

 #7
20250302941
2025-10-02

Application of an Immunogenic or Vaccine Composition

 #8
20250302939
2025-10-02

VACCINE FOR HUMAN T-LYMPHOTROPIC VIRUS-1

 #9
20250295759
2025-09-25

METHOD FOR ENHANCING IMMUNITY

 #10
20250281592
2025-09-11

IMMUNOGENIC COMPOSITION WITH PROTEIN MICRO- AND NANOPARTICLES

 #11
20250276053
2025-09-04

ROTAVIRUS VACCINES

 #12
20250235532
2025-07-24

POLYMER-LIPID HYBRID NANOPARTICLES COMPRISING A LIPID AND A BLOCK COPOLYMER AS WELL AS METHODS OF MAKING AND USES THEREOF

 #13
20250235531
2025-07-24

MUCOSAL ADMINISTRATION METHODS AND FORMULATIONS

 #14
20250179526
2025-06-05

ADENOVIRUS VECTORS AND METHODS FOR USING ADENOVIRUS VECTORS

 #15
20250032603
2025-01-30

EXPRESSION OF THE SPIKE S GLYCOPROTEIN OF SARS-COV-2 FROM AVIAN PARAMYXOVIRUS TYPE 3 (APMV3)

 #16
20240366752
2024-11-07

VACCINE COMPOSITION FOR PREVENTION AGAINST COVID-19

 #17
20240358822
2024-10-31

ALLERGY TREATMENT

 #18
20240358818
2024-10-31

ANTIBODY-INDUCING POLYPEPTIDE AND VACCINE

 #19
20240325524
2024-10-03

COMPOSITIONS AND METHODS FOR INDUCING IMMUNE TOLERANCE

 #20
20240165219
2024-05-23

Application of an Immunogenic or Vaccine Composition Against COVID-19

 #21
20240108575
2024-04-04

METHODS FOR INDUCING AN IMMUNE RESPONSE VIA BUCCAL AND/OR SUBLINGUAL ADMINISTRATION OF A VACCINE

 #22
20240082150
2024-03-14

OCULAR COMPOSITIONS

 #23
20240042007
2024-02-08

Fluorocarbon-Linked Peptide Formulation

 #24
20240041760
2024-02-08

VACCINATION FOR PROTECTING POULTRY AGAINST A POULTRY PATHOGEN

 #25
20230406908
2023-12-21

Methods of using passive immunity to decrease transmission of infectious diseases

 #26
20230330205
2023-10-19

NOROVIRUS VACCINE

 #27
20230285553
2023-09-14

MATERIALS AND METHODS FOR MITIGATING IMMUNE-SENSITIZATION

 #28
20230279428
2023-09-07

ADENOVIRUS VECTORS AND METHODS FOR USING ADENOVIRUS VECTORS

 #29
20230233461
2023-07-27

ANTI-INFECTION AND ANTI-TUMOR MUCOSAL IMMUNE PREPARATION

 #30
20230181728
2023-06-15

ADJUVANTED CONJUGATE OPIOID VACCINE

 #31
20230158139
2023-05-25

COMPOSITIONS AND METHODS FOR ENHANCING INNATE IMMUNITY IN A SUBJECT FOR THE TREATMENT OF OR REDUCING THE ONSET OF A HEALTH CONDITION

 #32
20230129084
2023-04-27

COMPOSITE IMPLANTS

 #33
20230015570
2023-01-19

SAPOVIRUS VACCINES

 #34
20220184198
2022-06-16

COMPOSITION FOR MUCOSAL ADMINISTRATION TO AVIANS

 #35
20220175914
2022-06-09

Method and system for protecting monarch butterflies from pesticides

 #36
20220143376
2022-05-12

VACCINATION USING HIGH-DENSITY MICROPROJECTION ARRAY PATCH

 #37
20220135668
2022-05-05

Methods for Treating Psoriasis Using an Anti-IL-23 Antibody

 #38
20220096368
2022-03-31

Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine

 #39
20220049271
2022-02-17

Adenovirus vectors and methods for using adenovirus vectors

 #40
20220031826
2022-02-03

Vaccine for the prevention and treatment of C. difficile infections and the use thereof

 #41
20210386848
2021-12-16

Controlled release vaccines and methods of treating diseases and disorders

 #42
20210338709
2021-11-04

USES OF MODIFIED RNA ENCODING RETINALDEHYDE DEHYDROGENASE

 #43
20210268094
2021-09-02

Engineering gut commensal bacteria to express heterologous proteins in their outer membrane vesicles (OMVS) for delivery to the GI-tract

 #44
20210260183
2021-08-26

Rapid and prolonged immunologic-therapeutic

 #45
20210253635
2021-08-19

PEPTIDIC PROTEIN KINASE C INHIBITORS AND USES THEREOF

 #46
20210177963
2021-06-17

Method and system for protecting honey bees from pesticides

 #47
20210170011
2021-06-10

Streptococcal vaccine

 #48
20210138057
2021-05-13

Anti-microbial immunomodulation

 #49
20210038710
2021-02-11

Fluorocarbon-linked peptide formulation

 #50
20200345828
2020-11-05

Norovirus vaccine

 #51
20200338184
2020-10-29

Rapid and prolonged immunogic therapeutic

 #52
20200338183
2020-10-29

Rapid and prolonged immunologic therapeutic

 #53
20200330580
2020-10-22

Transcutaneous dosage formulation

 #54
20200289643
2020-09-17

Method and system for protecting honey bees from pesticides

 #55
20200237649
2020-07-30

METHODS FOR INDUCING AN IMMUNE RESPONSE VIA BUCCAL AND/OR SUBLINGUAL ADMINISTRATION OF A VACCINE

 #56
20200230223
2020-07-23

Immunogenic proteins against

#57
20200179502
2020-06-11

Recombinant mycobacterium as an immunotherapeutic agent for the treatment of cancer

 #58
20190338044
2019-11-07

NANOBODY VAGINAL ADMINISTRATION SYSTEM AND PREPARATION METHOD AND USE THEREOF

 #59
20190290754
2019-09-26

Vaccine composition comprising hepatitis B virus like particle as adjuvant

 #60
20190247484
2019-08-15

Anti-microbial immunomodulation

 #61
20190224311
2019-07-25

Adjuvants

 #62
20190192654
2019-06-27

Microparticulated Vaccines for the Oral or Nasal Vaccination and Boostering of Animals Including Fish

 #63
20190169300
2019-06-06

Combination of glucagon receptor antagonists and PI3K pathway inhibitors for the treatment of cancer

 #64
20190142934
2019-05-16

Method and system for protecting honey bees from fipronil pesticides

 #65
20190142923
2019-05-16

Controlled release vaccines and methods for treating diseases and disorders

 #66
20190135895
2019-05-09

Albumin variants and uses thereof

 #67
20190134178
2019-05-09

RAPID AND PROLONGED IMMUNOGENIC-THERAPEUTIC

 #68
20190099477
2019-04-04

Engineering gut commensal bacteria to express heterologous proteins in their outer membrane vesicles (OMVs) for delivery to the GI-tract

 #69
20190022018
2019-01-24

Biomembrane, closed structure with biomembrane characteristics or cellular compartment derived from natural sources and/or self-assembly techniques, preparation method and applications thereof

 #70
20180369365
2018-12-27

Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response

 #71
20180360738
2018-12-20

Anti-infection and anti-tumor mucosal immune preparation

 #72
20180200357
2018-07-19

Recombinant as an immunotherapeutic agent for the treatment of cancer

 #73
20180193448
2018-07-12

NOVEL MUCOSAL VACCINATION APPROACH FOR HERPES SIMPLEX VIRUS TYPE-2

 #74
20180185469
2018-07-05

Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome

 #75
20180133300
2018-05-17

Vaccine composition for treating or preventing shigellosis

 #76
20180117136
2018-05-03

Streptococcal vaccine

 #77
20180099043
2018-04-12

Methods to improve induction of IgA antibodies by vaccines

 #78
20180080044
2018-03-22

Swine influenza vaccine

 #79
20180071381
2018-03-15

Transcutaneous vaccine formulations and methods

 #80
20180043023
2018-02-15

DOSE SELECTION OF ADJUVANTED SYNTHETIC NANOCARRIERS

 #81
20180000724
2018-01-04

Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine

 #82
20170370946
2017-12-28

Sialylated fetuin-A as a marker of immunotherapy efficacy

 #83
20170340729
2017-11-30

COMPOSITION COMPRISING PEDV ANTIGENS AND METHODS FOR MAKING AND USING THE COMPOSITION

 #84
20170333551
2017-11-23

USE OF SUPERANTIGENS FOR IMPROVING MUCOSAL ALLERGEN SPECIFIC IMMUNOTHERAPY IN HUMAN BEINGS

 #85
20170296643
2017-10-19

vaccine combination

 #86
20170258894
2017-09-14

NOVEL MUCOSAL VACCINATION APPROACH FOR HERPES SIMPLEX VIRUS TYPE-2

 #87
20170253636
2017-09-07

Dual purpose universal influenza vaccine confers protective immunity against anthrax

 #88
20170224807
2017-08-10

Newcastle disease virus vectored avian vaccines

 #89
20170202908
2017-07-20

AGENT FOR PROMOTING SUBSTANCE INCORPORATION IN INTESTINAL TRACT

 #90
20170196970
2017-07-13

Adjuvant for mucosal vaccine

 #91
20170143822
2017-05-25

Antigen-loaded chitosan nanoparticles for immunotherapy

 #92
20170100475
2017-04-13

Induction of mucosal tolerance to antigens

 #93
20170087237
2017-03-30

Anti-microbial immunomodulation

 #94
20170087231
2017-03-30

ALLERGEN FOR PROPHYLACTIC TREATMENT OF ALLERGY

 #95
20170080078
2017-03-23

Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome

 #96
20170056497
2017-03-02

Method of treating protozoal gastrointestinal disorders in immunocompromised patients

 #97
20170037379
2017-02-09

Chimeric viruses presenting non-native surface proteins and uses thereof

 #98
20170021015
2017-01-26

Immunoadjuvant flagellin-based compounds and use thereof

 #99
20170021011
2017-01-26

Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases

 #100
20160324960
2016-11-10

Adjuvant for mucosal vaccine

 #101
20160280763
2016-09-29

Albumin variants and uses thereof

 #102
20160256542
2016-09-08

Use of a lipopeptide or lipoprotein as an adjuvant in therapeutic or prophylactic vaccinations

 #103
20160213773
2016-07-28

Mucosal vaccine composition

 #104
20160193327
2016-07-07

Mucosal vaccine composition

 #105
20160184425
2016-06-30

Efficient mucosal vaccination mediated by the neonatal Fc receptor

 #106
20160175426
2016-06-23

COMPOSITIONS FOR MUCUSAL DELIVERY, USEFUL FOR TREATING PAPILLOMAVIRUS INFECTIONS

 #107
20160158350
2016-06-09

Adjuvant compositions and methods of use

 #108
20160136294
2016-05-19

BIFUNCTIONAL PROTEIN ANCHORS

 #109
20160106826
2016-04-21

Vaccines against pathogenic and methods of using the same

 #110
20160095913
2016-04-07

Controlled release vaccines and methods of treating diseases and disorders

 #111
20160051661
2016-02-25

Fluorocarbon-linked peptide formulation

 #112
20160045591
2016-02-18

Vaccine and therapeutic delivery system

 #113
20160032253
2016-02-04

Attenuation of infectious bronchitis virus variant GA-13

 #114
20160022800
2016-01-28

Transcutaneous haemophilus influenzae vaccine formulations and methods

 #115
20160022797
2016-01-28

Rapid and prolonged immunologic-therapeutic

 #116
20150343048
2015-12-03

Attenuated EHEC and clostridial toxins TcdA and TcdB based vaccine for associated disease (CDAD)

 #117
20150328309
2015-11-19

Dose selection of adjuvanted synthetic nanocarriers

 #118
20150297713
2015-10-22

RSV mucosal vaccine

 #119
20150273072
2015-10-01

Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics

 #120
20150265696
2015-09-24

Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome

 #121
20150166679
2015-06-18

Secretory immunoglobulin complex

 #122
20150118319
2015-04-30

Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector

 #123
20150118261
2015-04-30

vaccine combination

 #124
20150037370
2015-02-05

Diatom-based vaccines

 #125
20140370056
2014-12-18

Mucosal vaccine using cationic nanogel

 #126
20140322266
2014-10-30

Induction of mucosal tolerance to antigens

 #127
20140322230
2014-10-30

Induction of mucosal tolerance to antigens

 #128
20140302089
2014-10-09

Pharmaceutical compositions comprising inactivated HIV viral particles and non-pathogenic lactobacilli for the induction of antigen-specific immunotolerance

 #129
20140234358
2014-08-21

Newcastle disease virus vectored avian vaccines

 #130
20140227312
2014-08-14

A1 moiety of cholera toxin A subunit as an adjuvant for mucosal and systemic vaccines

 #131
20140227307
2014-08-14

Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response

 #132
20140220059
2014-08-07

WT1 peptide cancer vaccine composition for mucosal administration

 #133
20140220058
2014-08-07

VACCINE COMPOSITION FOR TRANSDERMAL OR MUCOSAL ADMINISTRATION

 #134
20140120139
2014-05-01

Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine

 #135
20140112951
2014-04-24

Vaccine and drug delivery by intranasal application of vector and vector extracts

 #136
20140004193
2014-01-02

Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome

 #137
20130315956
2013-11-28

Newcastle disease virus and the use thereof as a vaccine

 #138
20130302360
2013-11-14

Mucosal adjuvant composition

 #139
20130266612
2013-10-10

Vaccine composition

 #140
20130189288
2013-07-25

Adjuvant compositions and methods of use

 #141
20130045232
2013-02-21

Mucosal vaccines

 #142
20130034584
2013-02-07

Agent for use in the topical or local treatment of cervical dysplasias

 #143
20120301494
2012-11-29

Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector

 #144
20120301466
2012-11-29

CHEMICALLY PROGRAMMABLE IMMUNITY

 #145
20120282293
2012-11-08

Multivalent live vector vaccine against -associated disease

 #146
20120276141
2012-11-01

ENV POLYPEPTIDE COMPLEXES AND METHODS OF USE

 #147
20120244185
2012-09-27

IMMUNIZATION STRATEGY TO PREVENT H1N1 INFECTION

 #148
20120213780
2012-08-23

Efficient mucosal vaccination mediated by the neonatal Fc receptor

 #149
20120195928
2012-08-02

Compositions for and methods of inducing mucosal immune responses

 #150
20120171244
2012-07-05

MUCOSAL BOOSTING FOLLOWING PARENTERAL PRIMING

 #151
20120156258
2012-06-21

Adjuvant or pharmaceutical preparation for transdermal or transmucosal administration

 #152
20120122185
2012-05-17

Chimeric viruses presenting non-native surface proteins and uses thereof

 #153
20120121645
2012-05-17

SUPRALINGUAL VACCINES AND APPLICATORS

 #154
20120114693
2012-05-10

NUCLEIC ACID MUCOSAL IMMUNIZATION

 #155
20120100164
2012-04-26

SUPPRESSION OF A HYPERSENSITIVITY IMMUNE RESPONSE WITH UNRELATED ANTIGEN DERIVED FROM ALLERGEN SOURCE MATERIAL

 #156
20120070453
2012-03-22

Methods for preparing and delivering adjuvant compositions

 #157
20120064169
2012-03-15

Multiple antigen delivery system using hepatitis E virus-like particle

 #158
20120040010
2012-02-16

Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish

 #159
20120039935
2012-02-16

METHODS OF TREATING MEASLES INFECTIOUS DISEASE IN MAMMALS

 #160
20120027841
2012-02-02

NOVEL MUCOSAL VACCINATION APPROACH FOR HERPES SIMPLEX VIRUS TYPE-2

 #161
20120027806
2012-02-02

Dose selection of adjuvanted synthetic nanocarriers

 #162
20120014991
2012-01-19

NOVEL, NON-ANTIGENIC, MUCOSAL ADJUVANT FORMULATION WHICH MODULATES THE EFFECTS OF SUBSTANCES, INCLUDING VACCINE ANTIGENS, IN CONTACT WITH MUCOSAL BODY SURFACES

 #163
20110318348
2011-12-29

INDUCTION OF MUCOSAL IMMUNE RESPONSES BY MUCOSAL DELIVERY PENTABODY COMPLEX (MDPC)

 #164
20110305726
2011-12-15

Infectious bronchitis vaccines derived from IB-QX-like vaccine strains

 #165
20110293723
2011-12-01

SYNTHETIC NANOCARRIER COMBINATION VACCINES

 #166
20110293701
2011-12-01

MULTIVALENT SYNTHETIC NANOCARRIER VACCINES

 #167
20110293700
2011-12-01

NANOCARRIER COMPOSITIONS WITH UNCOUPLED ADJUVANT

 #168
20110287051
2011-11-24

PARAPOXVIRUS VECTORS

 #169
20110282036
2011-11-17

BSA-specific antibodies

 #170
20110268762
2011-11-03

IMMUNIZATION OF AVIANS BY MUCOSAL ADMINISTRATION OF NON-REPLICATING VECTORED VACCINES

 #171
20110256176
2011-10-20

Herpes simplex virus combined subunit vaccines and methods of use thereof

 #172
20110236685
2011-09-29

Therapeutic calcium phosphate particles and methods of manufacture and use

 #173
20110223197
2011-09-15

Mucosal and Systemic Immunization with Alphavirus Replicon Particles

 #174
20110223195
2011-09-15

COMPOSITION COMPRISING CHITOSAN FOR OCULAR ADMINISTRATION OF VACCINE(S) TO AVIANS

 #175
20110206729
2011-08-25

MUCOSAL VACCINE USING CATIONIC NANOGEL

 #176
20110195091
2011-08-11

Avian Influenza Virus Antigen, and Booster Immunization Method for Avian Influenza Vaccine in Combination with Mucosal Adjuvant Which is Effective Through Oral Administration

 #177
20110189187
2011-08-04

Immunogenic compositions for the prevention and treatment of meningococcal disease

 #178
20110159030
2011-06-30

MUCOSAL COMBINATION VACCINES FOR BACTERIAL MENINGITIS

 #179
20110150912
2011-06-23

Avian influenza virus live attenuated vaccine and uses thereof

 #180
20110143994
2011-06-16

COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE AND ALLERGIC DISEASES

 #181
20110142879
2011-06-16

INFECTIOUS CLONES

 #182
20110129502
2011-06-02

Immunogenic constructs

 #183
20110123571
2011-05-26

Use of bacterium for manufacture of a vaccine

 #184
20110112509
2011-05-12

Microneedle device, and method for enhancing the efficacy of influenza vaccine by using microneedle device

 #185
20110110971
2011-05-12

Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same

 #186
20110110962
2011-05-12

Immunoadjuvant flagellin-based compounds and use thereof

 #187
20110104263
2011-05-05

Claudin-4 binding peptides, compositions and methods of use

 #188
20110104200
2011-05-05

Methods, compositions and kits for vegetative cell-based vaccines and spore-based vaccines

 #189
20110091496
2011-04-21

METHODS AND COMPOSITIONS FOR THE DELIVERY OF VACCINES TO DISRUPTED EPITHELIUM

 #190
20110081382
2011-04-07

Treatment and prevention of tuberculosis

 #191
20110064772
2011-03-17

Viral adjuvants

 #192
20110033493
2011-02-10

VACCINE

 #193
20100330112
2010-12-30

Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response

 #194
20100303923
2010-12-02

Endotoxin adsorbent for the prevention and treatment of autoimmune diseases

 #195
20100291115
2010-11-18

PHARMACEUTICAL COMPOSITION FOR THE SUBLINGUAL ADMINISTRATION OF VACCINES, METHOD FOR THE PREPARATION OF THE SAME AND USES THEREOF

 #196
20100260853
2010-10-14

COMPOSITIONS FOR PULMONARY DELIVERY

 #197
20100255029
2010-10-07

Newcastle disease virus vectored avian vaccines

 #198
20100247535
2010-09-30

Chemically programmable immunity

 #199
20100196411
2010-08-05

Yeast-Based Vaccine for Inducing an Immune Response

 #200
20100172941
2010-07-08

Adjuvant compositions and methods of use

 #201
20100172920
2010-07-08

Method of inducing immune tolerance to type I diabetes

 #202
20100167352
2010-07-01

Infectious clones

 #203
20100158946
2010-06-24

Secretory IgA and IgG Antibody Inducer

 #204
20100158943
2010-06-24

ADMINISTRATION ROUTES FOR PRIMING/BOOSTING WITH INFLUENZA VACCINES

 #205
20100104562
2010-04-29

Enhancing efficacy of vaccines administered via the respiratory tract

 #206
20100074914
2010-03-25

DNA vaccine comprising CTGF-encoding DNA construct and applications thereof

 #207
20100047329
2010-02-25

Novel Vaccination Carrier

 #208
20100047327
2010-02-25

Adjuvant for Transdermal or Transmucosal Administration and Pharmaceutical Preparation Containing the Same

 #209
20100008951
2010-01-14

Flu vaccine admixture of mannan and flu antigen

 #210
20100008944
2010-01-14

HERPES SIMPLEX VIRUS MUTANT AND USES THEREFORE

 #211
20090311334
2009-12-17

MUCOSAL IMMUNOGENIC SUBSTANCES COMPRISING A POLYINOSINIC ACID - POLYCYTIDILIC ACID BASED ADJUVANT

 #212
20090311290
2009-12-17

Urogenital or anorectal transmucosal vaccine delivery system

 #213
20090306344
2009-12-10

Method of reducing the viscosity of mucus

 #214
20090304750
2009-12-10

NOVEL PRIME-BOOST COMBINATIONS OF ATTENUATED MYCOBACTERIUM

 #215
20090304733
2009-12-10

Vaccine comprising recombinant ct or lt toxin

 #216
20090297560
2009-12-03

Oral vaccine for

#217
20090285858
2009-11-19

Prevention of allergy in children

 #218
20090263414
2009-10-22

Bifunctional protein anchors

 #219
20090226489
2009-09-10

Viral vaccine composition, process and methods of use

 #220
20090203593
2009-08-13

Immunogenic constructs

 #221
20090175903
2009-07-09

MEASLES SUBUNIT VACCINE

 #222
20090155307
2009-06-18

IMMUNOSTIMULATORY NUCLEIC ACID OIL-IN-WATER FORMULATIONS AND RELATED METHODS OF USE

 #223
20090148389
2009-06-11

Induction of mucosal tolerance to antigens

 #224
20090130131
2009-05-21

Mucosal vaccine enabling switching from production of IgA antibody to production of both of IgA and IgG antibodies

 #225
20090130127
2009-05-21

Adjuvant or Pharmaceutical Preparation for Transdermal or Transmucousal Administration

 #226
20090117145
2009-05-07

Composition and method for enhancing immune response

 #227
20090081235
2009-03-26

PSEUDOMONAS EXOTOXIN A-LIKE CHIMERIC IMMUNOGENS FOR ELICITING A SECRETORY IGA-MEDIATED IMMUNE RESPONSE

 #228
20090004246
2009-01-01

Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs

 #229
20090004203
2009-01-01

METHODS OF TREATING MEASLES INFECTIOUS DISEASE IN MAMMALS

 #230
20080311138
2008-12-18

Adjuvant Activity of Gastrointestinal Peptides

 #231
20080286297
2008-11-20

Chimeric Carrier Molecules for the Production of Mucosal Vaccines

 #232
20080279891
2008-11-13

Viral adjuvants

 #233
20080274140
2008-11-06

Vaccines and Methods for Using the Same

 #234
20080267963
2008-10-30

Methods of Cancer Treatment/Prevention Using Cancer Cell-Specific Surface Antigens

 #235
20080220028
2008-09-11

ARCHAEAL POLAR LIPID AGGREGATES FOR ADMINISTRATION TO ANIMALS

 #236
20080199492
2008-08-21

Env polypeptide complexes and methods of use

 #237
20080159984
2008-07-03

Compositions capable of facilitating penetration across a biological barrier

 #238
20080139494
2008-06-12

Methods of inducing mucosal immunity

 #239
20080102112
2008-05-01

CHLAMYDIA VACCINES

 #240
20080069844
2008-03-20

Mucosal vaccine adjuvants containing bacterial flagellins as an active component

 #241
20080069837
2008-03-20

Composition and method for treating cancer using herpes virus

 #242
20080063645
2008-03-13

Endotoxin-adsorbent for the prevention and treatment of autoimmune diseases

 #243
20080050395
2008-02-28

METHODS FOR PREPARING AND DELIVERING ADJUVANT COMPOSITIONS

 #244
20080031897
2008-02-07

PREVENTION OF ALLERGY IN CHILDREN

 #245
20080031849
2008-02-07

Use of immunogens to treat or prevent, in malignant tumors, the immune or vascular disorders induced by extracellular factors

 #246
20080026988
2008-01-31

Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen

 #247
20080003239
2008-01-03

Yeast-based vaccine for inducing an immune response

 #248
20070292454
2007-12-20

Therapeutic calcium phosphate particles and methods of manufacture and use

 #249
20070248573
2007-10-25

Chimeric Bacteriophages, Chimeric Phage-Like Particles, and Chimeric Phage Ghost Particles, Methods for Their Production and Use

 #250
20070219149
2007-09-20

Novel Vaccine Containing Adjuvant Capable Of Inducing Mucosal Immunity

 #251
20070202130
2007-08-30

Anthrax antigens and methods of use

 #252
20070196391
2007-08-23

Mucosal boosting following parenteral priming

 #253
20070166239
2007-07-19

Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant

 #254
20070154494
2007-07-05

Anthrax vaccines and delivery methods

 #255
20070141079
2007-06-21

ANTIBODY PRODUCTION IN FARM ANIMALS

 #256
20070141073
2007-06-21

Antigen-drug vehicle enabling transmucosal and transdermal administration, and method of inducing mucosal immunity and mucosal vaccine and DDS using the same

 #257
20070104739
2007-05-10

Equine protozoal myeloencephalitis vaccine

 #258
20070087013
2007-04-19

Orally-administered live bacterial vaccines for plague

 #259
20070082010
2007-04-12

Urogenital or anorectal transmucosal vaccine delivery system

 #260
20070020192
2007-01-25

Receptor specific transepithelial transport of therapeutics

 #261
20070009951
2007-01-11

Gene expression vaccine

 #262
20060287263
2006-12-21

Methods and compositions for inducing antigen-specific immune responses

 #263
20060257414
2006-11-16

Mycoplasma gallisepticum formulation

 #264
20060246088
2006-11-02

Use of HIV-1 gp120 and gp160 proteins modified in the V3 loop for the preparation of vaccine compositions and formulations containing the same

 #265
20060246087
2006-11-02

Hetero type pentamer recombinant vaccine

 #266
20060228375
2006-10-12

Induction of mucosal immunity by vaccination via the skin route

 #267
20060165722
2006-07-27

Peptides for delivery of mucosal vaccines

 #268
20060153882
2006-07-13

Anti-allergic pharmaceutical composition containing at least one allergen and at least on antihistamine compound

 #269
20060153863
2006-07-13

Use of inactive immunosuppressive and/or angiogenic immunogenic proteins, for producing secretory IgA's

 #270
20060153828
2006-07-13

Method of reducing complement - mediated disruption of cells

 #271
20060147466
2006-07-06

Mucosal combination vaccines for bacterial meningitis

 #272
20060121064
2006-06-08

Method of preventive treatment of allergy by mucosal administration of an allergy vaccine

 #273
20060051374
2006-03-09

Compositions and methods for mucosal vaccination

 #274
20060045882
2006-03-02

Developing oral tolerance for airborne allergens

 #275
20060013831
2006-01-19

Composition and method for enhancing immune response

 #276
20060002962
2006-01-05

Method of treating allergy and infection by eliciting an IGA antibody response

 #277
20050287168
2005-12-29

Recombinant spores

 #278
20050276813
2005-12-15

Use of a lipopeptide or lipoprotein as an adjuvant in therapeutic or prophylactic vaccinations

 #279
20050232981
2005-10-20

Compositions capable of facilitating penetration across a biological barrier

 #280
20050232897
2005-10-20

Mucosal cytotoxic T lymphocyte responses

 #281
20050220783
2005-10-06

Antibody production in farm animals

 #282
20050208123
2005-09-22

Chylamydia vaccine

 #283
20050208020
2005-09-22

Enhancement of vaccine-induced immune responses and protection by heterologous boosting with alphavirus replicon vaccines

 #284
20050180967
2005-08-18

Polyclonal antibody composition for treating allergy

 #285
20050175630
2005-08-11

Immunogenic compositions and methods of use thereof

 #286
20050175621
2005-08-11

Adjuvant composition comprising FHA protein or a fragment of FHA protein in its free form

 #287
20050169938
2005-08-04

Plant lectins as mucosal adjuvants

 #288
20050152919
2005-07-14

Measles subunit vaccine

 #289
20050112142
2005-05-26

Methods and compositions for treatment and prevention of HSV-2 infections and conditions

 #290
20050089520
2005-04-28

Antibody stimulating il-ira production

 #291
20050079171
2005-04-14

Pseudomonas exotoxin A-like chimeric immunogens for eliciting a secretory IgA-mediated immune response

 #292
20050075298
2005-04-07

Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa

 #293
20050013812
2005-01-20

Vaccines using pattern recognition receptor-ligand:lipid complexes

 #294
16996740
2021-10-19

Adenovirus vectors and methods for using adenovirus vectors

 #295
14875421
2018-03-13

Kexin-based vaccines to prevent or treat fungal infections